<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27587" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Prader-Willi Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fermin Gutierrez</surname>
            <given-names>Maria A.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Daley</surname>
            <given-names>Sharon F.</given-names>
          </name>
          <aff>Cape Cod Hospital, Hyannis, MA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mendez</surname>
            <given-names>Magda D.</given-names>
          </name>
          <aff>Lincoln Medical Center/Weil Cornell</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maria Fermin Gutierrez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sharon Daley declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Magda Mendez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27587.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Prader-Willi syndrome is a rare and complex genetic disorder that impacts the metabolic, endocrine, and neurologic systems. The syndrome manifests with severe hypotonia and feeding difficulties during the early years of life, leading to global developmental delays. Patients with&#x000a0;Prader-Willi syndrome often exhibit behavioral and intellectual challenges. The syndrome is characterized by recognizable facial features, strabismus (crossed eyes), and musculoskeletal abnormalities. Diagnosis, evaluation, and management involve an interprofessional clinical team to address the multifaceted aspects of PWS and improve patient care.</p>
        <p>The CME activity emphasizes an interprofessional clinical team approach to address the multifaceted aspects of Prader-Willi syndrome effectively. Clinicians will gain insight into the unique challenges presented by patients with PWS, including hyperphagia, a distinct desire to eat that contributes to obesity onset by age 3. Participants can expect to enhance their ability to recognize and manage the disorder comprehensively, ultimately improving the care provided to individuals affected by Prader-Willi syndrome.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify characteristic clinical features of Prader-Willi syndrome to facilitate early diagnosis and intervention.</p></list-item><list-item><p>Assess the impact of&#x000a0;Prader-Willi syndrome&#x000a0;on patients' developmental, behavioral, and intellectual aspects, tailoring care plans accordingly.</p></list-item><list-item><p>Implement evidence-based interventions and management strategies for Prader-Willi syndrome, considering the complex nature of the disorder.</p></list-item><list-item><p>Collaborate with specialists and support services to comprehensively address the diverse healthcare needs of individuals with&#x000a0;Prader-Willi syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27587&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27587">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27587.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Prader-Willi syndrome is a rare, complex genetic&#x000a0;condition&#x000a0;affecting the metabolic, endocrine, and neurologic systems. It stands out as the predominant syndromic manifestation of obesity. Patients with Prader-Willi syndrome exhibit behavioral, developmental, and intellectual difficulties characterized by severe hypotonia&#x000a0;and feeding difficulties in the first years of life. Global developmental delay, hyperphagia,&#x000a0;and the onset of obesity&#x000a0;manifest around&#x000a0;the age of 3.&#x000a0;Individuals with Prader-Willi syndrome display distinctive&#x000a0;facial features, strabismus, and musculoskeletal abnormalities.</p>
        <p>Many patients with Prader-Willi syndrome have short stature due to growth hormone deficiency (GHD). Additionally, they face hypothalamic dysfunction,&#x000a0;contributing to&#x000a0;various endocrinopathies, including hypogonadism, hypothyroidism, central adrenal insufficiency, and reduced bone mineral density. Continuous monitoring by an endocrinologist is crucial for these patients throughout their lifespan.<xref ref-type="bibr" rid="article-27587.r1">[1]</xref></p>
      </sec>
      <sec id="article-27587.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Prader-Willi syndrome&#x000a0;results from the absence of gene expression&#x000a0;of the paternally inherited genes on the 15q11.2-q13 chromosome. Approximately 70% of cases result from errors in genomic imprinting due to a paternal deletion, while maternal uniparental disomy&#x000a0;is responsible for about 25% of cases. Fewer cases stem from defects in the imprinting center, such as microdeletions or epimutations on chromosome 15.<xref ref-type="bibr" rid="article-27587.r1">[1]</xref><xref ref-type="bibr" rid="article-27587.r2">[2]</xref>&#x000a0;</p>
        <p>While most occurrences of&#x000a0;Prader-Willi syndrome&#x000a0;are sporadic, familial instances may&#x000a0;occur when paternal genes carry a microdeletion in the imprinting center inherited from&#x000a0;the paternal grandmother. Prader-Willi syndrome&#x000a0;was the first genetic disorder&#x000a0;identified to be caused by genomic imprinting, where the expression of the gene depends on the parental sex donating the affected gene.&#x000a0;</p>
      </sec>
      <sec id="article-27587.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Prader-Willi syndrome has a prevalence of 1 in every 20,000 to 30,000 births.<xref ref-type="bibr" rid="article-27587.r3">[3]</xref>. Worldwide, around 400,000 individuals are affected by Prader-Willi syndrome, with 20,000 residing&#x000a0;in the United States.<xref ref-type="bibr" rid="article-27587.r2">[2]</xref>&#x000a0;It stands as the most prevalent genetic&#x000a0;cause of life-threatening obesity.<xref ref-type="bibr" rid="article-27587.r2">[2]</xref>&#x000a0;Both females and males&#x000a0;are equally affected, with no&#x000a0;discernible differences noted among races and ethnicities.<xref ref-type="bibr" rid="article-27587.r4">[4]</xref></p>
      </sec>
      <sec id="article-27587.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>During birth,&#x000a0;individuals with&#x000a0;Prader-Willi syndrome exhibit&#x000a0;growth parameters&#x02014;including weight, length, and body mass index&#x02014;15% to 20% smaller than their unaffected siblings, indicating decreased prenatal growth.&#x000a0;Observable prenatal hypotonia&#x000a0;is evident through decreased fetal movement and abnormal positions during delivery, contributing to a higher incidence of assisted births and Cesarean section deliveries.<xref ref-type="bibr" rid="article-27587.r5">[5]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-27587.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical manifestations of&#x000a0;Prader-Willi syndrome vary across different age groups, constituting a range of features. Symptoms may manifest at birth and tend to become more apparent over time.</p>
        <p>Hypotonia is&#x000a0;a common&#x000a0;feature&#x000a0;in nearly all infants with&#x000a0;Prader-Willi syndrome. This is accompanied by a poor sucking reflex,&#x000a0;resulting in feeding difficulties, diminished muscle mass and strength,&#x000a0;poor weight gain&#x000a0;early in life, and&#x000a0;the need for specialized feeding devices or&#x000a0;extended periods of enteral nutrition. Prenatally, there is reduced fetal movement, and the onset of "quickening," the perception of movement by the pregnant mother, occurs later in the pregnancy.<xref ref-type="bibr" rid="article-27587.r2">[2]</xref><xref ref-type="bibr" rid="article-27587.r5">[5]</xref></p>
        <p>Prader-Willi syndrome is characterized by dysmorphic facial features, including a narrow frontal diameter, almond-shaped palpebral fissures, strabismus, a slender nasal bridge, a thin upper vermillion border with downturned mouth corners, and enamel hypoplasia. During physical examination, small hands and feet are frequently observed, although these characteristics may not be&#x000a0;evident at birth but develop&#x000a0;later.<xref ref-type="bibr" rid="article-27587.r2">[2]</xref><xref ref-type="bibr" rid="article-27587.r5">[5]</xref>&#x000a0;</p>
        <p>Developmental delays and behavioral issues are also common. Motor developmental delay is expected, with the attainment of early milestones typically occurring at about&#x000a0;half the usual pace.<xref ref-type="bibr" rid="article-27587.r5">[5]</xref>&#x000a0;The&#x000a0;median age of independent walking is 27 months.<xref ref-type="bibr" rid="article-27587.r6">[6]</xref> Language impairment commonly occurs, and intellectual and learning disabilities typically&#x000a0;manifest by school age.<xref ref-type="bibr" rid="article-27587.r7">[7]</xref>&#x000a0;Behavioral&#x000a0;problems, such as&#x000a0;anxiety, obsessive-compulsive disorder, temper outbursts, and self-inflicted injuries, are prevalent in almost all individuals with Prader-Willi syndrome.<xref ref-type="bibr" rid="article-27587.r4">[4]</xref></p>
        <p>GHD is the most&#x000a0;frequently reported endocrinopathy in patients with Prader-Willi syndrome. Short stature&#x000a0;may present in early childhood and&#x000a0;is seen by the second decade of life, accompanied by accelerated weight gain and truncal obesity (see <bold>Image.&#x000a0;</bold>Prader-Willi Syndrome Phenotype). Although the pathogenesis is unclear, insulin-like growth factor 1 (IGF-1) is deficient or subnormal in&#x000a0;nearly all patients with Prader-Willi syndrome. The growth hormone secretion test and the 24-hour spontaneous secretion of growth hormone show impairment.<xref ref-type="bibr" rid="article-27587.r1">[1]</xref><xref ref-type="bibr" rid="article-27587.r5">[5]</xref>&#x000a0;Patients&#x000a0;display short stature and growth deceleration, failing to achieve the typical puberty growth&#x000a0;spurt.<xref ref-type="bibr" rid="article-27587.r8">[8]</xref></p>
        <p>The progression leading to the hallmark hyperphagia and obesity in Prader-Willi syndrome can be described in 4&#x000a0;phases (see&#x000a0;<bold>Table.</bold> Phases of Prader-Willi Syndrome)</p>
        <table-wrap id="article-27587.table0" position="float" orientation="portrait">
          <caption>
            <title>Table 1. Phases of Prader-Willi Syndrome</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">Phase</td>
                <td rowspan="1" colspan="1">Presentation</td>
                <td rowspan="1" colspan="1">Age</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">1a</td>
                <td rowspan="1" colspan="1">Infants are hypotonic and feed poorly with slow weight gain</td>
                <td rowspan="1" colspan="1">Birth to&#x000a0;9 to 15 &#x000a0;months</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">1b</td>
                <td rowspan="1" colspan="1">Steady growth with a typical rate of weight gain</td>
                <td rowspan="1" colspan="1">9 to 24 months</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">2a</td>
                <td rowspan="1" colspan="1">Weight gain without significantly increasing caloric intake or appetite</td>
                <td rowspan="1" colspan="1">2 to 4.5 years</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">2b</td>
                <td rowspan="1" colspan="1">Frank hyperphagia and heightened interest in food</td>
                <td rowspan="1" colspan="1">4.5 years to 8 years&#x000a0;<xref ref-type="bibr" rid="article-27587.r9">[9]</xref>&#x000a0;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">3</td>
                <td rowspan="1" colspan="1">Increased hyperphagia, food-seeking behaviors, lack satiety</td>
                <td rowspan="1" colspan="1">8 years to adult</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">4</td>
                <td rowspan="1" colspan="1">Insatiable appetite resolves</td>
                <td rowspan="1" colspan="1">Adulthood&#x000a0;<xref ref-type="bibr" rid="article-27587.r2">[2]</xref><xref ref-type="bibr" rid="article-27587.r5">[5]</xref>&#x000a0;</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>In&#x000a0;Prader-Willi syndrome, central obesity is typical, leading to significant complications&#x000a0;and increased morbidity and mortality.<xref ref-type="bibr" rid="article-27587.r5">[5]</xref>&#x000a0;In adults, hyperphagia can result in choking, which can even&#x000a0;cause sudden death.<xref ref-type="bibr" rid="article-27587.r10">[10]</xref>&#x000a0;Food-seeking behaviors include binge eating and consuming garbage and non-food items. The biological mechanism for this impaired satiety is unclear. In some studies, ghrelin levels are elevated in patients with&#x000a0;Prader-Willi syndrome compared to weight and age-matched controls.<xref ref-type="bibr" rid="article-27587.r11">[11]</xref><xref ref-type="bibr" rid="article-27587.r12">[12]</xref>&#x000a0;</p>
        <p>Hypogonadism is&#x000a0;prevalent in patients with&#x000a0;Prader-Willi syndrome. Almost all&#x000a0;affected males experience cryptorchidism, often necessitating&#x000a0;orchiopexy. Male infants also&#x000a0;display scrotal hypoplasia, while females may&#x000a0;exhibit hypoplasia or absence of the labia minora and clitoral hypoplasia.<xref ref-type="bibr" rid="article-27587.r13">[13]</xref> Penile size is&#x000a0;initially reported as&#x000a0;average at birth but later falls&#x000a0;2 standard deviations below the normal curve. As a result of smaller penile size and increased fat pad over the pubic area, standing urination can pose challenges, and a short course of testosterone&#x000a0;may aid&#x000a0;in potty training.&#x000a0;Upon reaching puberty at&#x000a0;the typical age, there is an increase in testosterone levels, but they remain abnormally low. Puberty arrest is evident at Tanner stage 3 in sexual maturity rating, characterized by testicular failure and a small testicular size persisting into adulthood.</p>
        <p>Females with&#x000a0;Prader-Willi syndrome are born with external genitalia hypoplasia. While puberty usually begins at&#x000a0;the&#x000a0;typical age, breast development may be significantly delayed. Spontaneous menarche is rare in&#x000a0;Prader-Willi syndrome,&#x000a0;typically occurring around age 20. Estrogen and luteinizing hormone levels are low to normal, while follicular stimulating hormone levels are normal to high, indicating central and primary defects.</p>
        <p>Both males and females with&#x000a0;Prader-Willi syndrome are considered infertile, and there is a notable incidence of premature adrenarche in both genders. Approximately&#x000a0;14% to 30% of cases&#x000a0;are associated&#x000a0;with advanced bone age,&#x000a0;potentially&#x000a0;influenced by the presence&#x000a0;of obesity.<xref ref-type="bibr" rid="article-27587.r1">[1]</xref></p>
        <p>Additional&#x000a0;manifestations of&#x000a0;Prader-Willi syndrome include sleep disorders, thick viscous saliva, high pain threshold, decreased vomiting, epilepsy, temperature instability, scoliosis/kyphosis, and osteoporosis. Skin, iris, and hair hypopigmentation relative to that expected for family background occurs in 30% to 50% of patients with&#x000a0;Prader-Willi syndrome.<xref ref-type="bibr" rid="article-27587.r14">[14]</xref>&#x000a0;Obesity associated with&#x000a0;Prader-Willi syndrome leads to many predictable complications, including cardiovascular disease, nonalcoholic fatty liver disease (NAFLD), dyslipidemia, diabetes, sleep apnea, and respiratory failure.&#x000a0;</p>
      </sec>
      <sec id="article-27587.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>When clinical features suggest&#x000a0;Prader-Willi syndrome,&#x000a0;the recommended&#x000a0;diagnostic approach involves&#x000a0;molecular testing with DNA methylation analysis, which&#x000a0;detects over 99% of cases.<xref ref-type="bibr" rid="article-27587.r15">[15]</xref>&#x000a0;A positive result prompts further testing to identify the presence of a deletion, maternal disomy, or imprinting defect. Chromosome analysis&#x000a0;using fluorescence in situ hybridization can identify the 15q11-q13 deletion, while chromosomal microarray can&#x000a0;reveal&#x000a0;maternal disomy.<xref ref-type="bibr" rid="article-27587.r2">[2]</xref><xref ref-type="bibr" rid="article-27587.r16">[16]</xref>&#x000a0;In&#x000a0;resource-rich countries, diagnosis often&#x000a0;occurs early,&#x000a0;around&#x000a0;2 months of age. However, confirmation may be delayed until around 4 years of age, especially in tertiary referral centers.<xref ref-type="bibr" rid="article-27587.r7">[7]</xref></p>
        <p>Additional studies&#x000a0;tailored to individual patient needs include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Thyroid function tests to&#x000a0;determine the presence of hypothyroidism, especially when considering growth hormone treatment&#x000a0;<xref ref-type="bibr" rid="article-27587.r2">[2]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Liver function tests, serum IGF-1, and insulin-like growth factor binding protein-3 to&#x000a0;evaluate possible GHD<xref ref-type="bibr" rid="article-27587.r2">[2]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Fasting glucose level, hemoglobin A1c, and oral glucose tolerance test&#x000a0;if diabetes is suspected</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Polysomnography (sleep study) to diagnose sleep disorders</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Dual x-ray absorptiometry (DXA scan) to assess bone mineralization and composition<xref ref-type="bibr" rid="article-27587.r2">[2]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27587.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Managing patients with&#x000a0;Prader-Willi syndrome depends upon the affected individual's age and involves evaluating and monitoring&#x000a0;various organ systems. Infants with Prader-Willi syndrome exhibit muscular hypotonia, difficulty feeding, and&#x000a0;inadequate weight gain, often&#x000a0;necessitating a feeding team evaluation for specialized feeding techniques and the incorporation of high-calorie supplements or formulas.&#x000a0;As hyperphagia&#x000a0;emerges&#x000a0;in childhood, restricting food intake is critical. Most patients have&#x000a0;reduced energy needs, requiring approximately 70% of the calories compared to their age-matched peers without&#x000a0;Prader-Willi syndrome. While an ideal calorie-restricted diet may&#x000a0;lack sufficient vitamins and minerals, supplements should be prescribed to meet daily requirements, with caution against gummy vitamins due to their high caloric content and the risk of overdose, given their candy-like taste.</p>
        <p>Caregivers implement&#x000a0;physical barriers,&#x000a0;such as locking food cupboards and refrigerators and close supervision, to enforce food restrictions.&#x000a0;Individuals with hyperphagia may&#x000a0;neglect&#x000a0;thoroughly chewing food, elevating the risk of choking and thus emphasizing the critical need for caregiver training in the Heimlich maneuver. In cases of severe obesity in older children and adults, treatment with weight loss medications and bariatric surgery can be considered.&#x000a0;</p>
        <p>Hypotonia and motor&#x000a0;delays in individuals with&#x000a0;Prader-Willi syndrome can be effectively addressed through physical and occupational therapy. Additionally, early treatment with recombinant human growth hormone (rhGH) improves strength, physical function, and muscle development in pediatric patients with&#x000a0;Prader-Willi syndrome. Formal growth hormone testing is not a prerequisite, and&#x000a0;treatment&#x000a0;with rhGH in children can be initiated upon diagnosis, preferably before the first birthday.<xref ref-type="bibr" rid="article-27587.r7">[7]</xref><xref ref-type="bibr" rid="article-27587.r17">[17]</xref>&#x000a0;Continuous treatment with rhGH during adolescence is recommended to maximize linear growth.</p>
        <p>Adults,&#x000a0;particularly&#x000a0;those with&#x000a0;persistent GHD, may also benefit from&#x000a0;rhGH treatment. Close height monitoring is essential for all children and teenagers with&#x000a0;Prader-Willi syndrome. While the disadvantage of rhGH is the need for daily or weekly injections, the treatment is associated with&#x000a0;improved linear growth,&#x000a0;reduced obesity, and&#x000a0;enhanced&#x000a0;bone density and motor function.&#x000a0;Patients treated with rhGH during childhood&#x000a0;are&#x000a0;likelier to&#x000a0;approach their predicted final adult height.<xref ref-type="bibr" rid="article-27587.r8">[8]</xref>&#x000a0;</p>
        <p>Cryptorchidism is&#x000a0;observed in most young boys with&#x000a0;Prader-Willi syndrome. While human chorionic gonadotropin treatment may be effective in some cases,&#x000a0;the majority require orchiopexy.<xref ref-type="bibr" rid="article-27587.r1">[1]</xref>&#x000a0;Consultation with an endocrinologist is recommended at puberty since hormonal replacement may be indicated for delayed puberty. Treatment with testosterone is indicated for boys with delayed puberty,&#x000a0;while girls receive estrogen replacement in the form of transdermal patches until the&#x000a0;onset of menarche.<xref ref-type="bibr" rid="article-27587.r1">[1]</xref><xref ref-type="bibr" rid="article-27587.r5">[5]</xref></p>
        <p>Most patients with&#x000a0;Prader-Willi syndrome experience&#x000a0;behavior or psychiatric diagnoses,&#x000a0;with about a quarter of children meeting the diagnostic criteria for autism spectrum disorder.<xref ref-type="bibr" rid="article-27587.r18">[18]</xref>&#x000a0;Adolescents and adults with mood disorders or psychoses may require medication and therapy.</p>
        <p>Behavioral strategies assist patients in understanding rules, schedules, expectations, and verbal cues, minimizing symptoms of compulsion and aggression.<xref ref-type="bibr" rid="article-27587.r7">[7]</xref>&#x000a0;Skin picking is frequent, and&#x000a0;a study demonstrated the benefits of treatment with oral guanfacine.<xref ref-type="bibr" rid="article-27587.r19">[19]</xref>&#x000a0;Cognitive impairment is prevalent in many individuals, and adults may exhibit accelerated cognitive decline with age. It is recommended that schoolchildren have an individualized educational plan (IEP),&#x000a0;while adults often thrive in a supervised vocational setting.</p>
        <p>Reduced&#x000a0;bone mineral density is typical, and patients should undergo evaluation&#x000a0;through DXA scans every&#x000a0;2 to&#x000a0;3 years,&#x000a0;starting from the&#x000a0;age of 5 years. Scoliosis is also common, and it is advisable to monitor pediatric patients during routine visits, referring them for orthopedic evaluation when indicated.&#x000a0;</p>
        <p>Hypothyroidism may also manifest, and routine&#x000a0;testing&#x000a0;is recommended to commence within&#x000a0;the first year.<xref ref-type="bibr" rid="article-27587.r20">[20]</xref>&#x000a0;Type 2 diabetes can emerge as a complication of severe obesity, and screening should be conducted if indicated. Sleep-disordered breathing,&#x000a0;a common complication of obesity, affects most children and young adults. Individuals experiencing daytime sleepiness and behavior problems should be evaluated for obstructive sleep apnea (OSA), and in some&#x000a0;cases, surgical intervention with tonsillectomy or adenotonsillectomy may be necessary.</p>
      </sec>
      <sec id="article-27587.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several disorders exhibit clinical features like&#x000a0;Prader-Willi syndrome and should be considered when diagnosing a patient with&#x000a0;Prader-Willi syndrome. Neonatal hypotonia&#x000a0;can also result from&#x000a0;neuropathies and myopathies like spinal myotonic dystrophy,&#x000a0;characterized by poor respiratory effort early in life.<xref ref-type="bibr" rid="article-27587.r5">[5]</xref>&#x000a0;Patients with Prader-Willi-like syndrome present with features resembling&#x000a0;Prader-Willi syndrome but differ genetically. Notable clinical features shared by both include hypotonia, short stature, obesity, and developmental delays.<xref ref-type="bibr" rid="article-27587.r21">[21]</xref></p>
        <p>Children with&#x000a0;craniopharyngioma, a rare tumor, may&#x000a0;exhibit&#x000a0;features that overlap with&#x000a0;Prader-Willi syndrome as a result of the treatment's impact on the hypothalamus.<xref ref-type="bibr" rid="article-27587.r5">[5]</xref>&#x000a0;The distinct presentation of&#x000a0;Prader-Willi syndrome involves a gradual progression from hypotonia with poor feeding and slow weight gain to hyperphagia, followed by severe obesity, setting it apart from other diseases.</p>
      </sec>
      <sec id="article-27587.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for patients with&#x000a0;Prader-Willi syndrome varies,&#x000a0;influenced by&#x000a0;the&#x000a0;timing of diagnosis and the&#x000a0;extent of complications. Initiating treatment early and preventing severe obesity&#x000a0;increases the likelihood of patients&#x000a0;attaining an average lifespan. However, due to intellectual disabilities, most affected individuals require supportive services&#x000a0;and&#x000a0;are&#x000a0;less likely to lead fully independent lives as adults.&#x000a0;</p>
        <p>Complications such as obesity, diabetes, and heart failure shorten life expectancy in&#x000a0;Prader-Willi syndrome. Death frequently occurs in the fourth decade when comorbidities are inadequately controlled. However, individuals with&#x000a0;Prader-Willi syndrome have the potential to reach the seventh decade if their weight is curbed.<xref ref-type="bibr" rid="article-27587.r2">[2]</xref><xref ref-type="bibr" rid="article-27587.r22">[22]</xref></p>
      </sec>
      <sec id="article-27587.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Numerous&#x000a0;Prader-Willi syndrome complications result from severe obesity but may also be related to musculoskeletal, neurologic, behavioral, and developmental conditions affecting multiple organ systems.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Respiratory: OSA, hypoventilation, aspiration pneumonia, and obesity-related respiratory failure&#x000a0;<xref ref-type="bibr" rid="article-27587.r23">[23]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cardiovascular: Hypertension and right-sided heart failure</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Gastrointestinal: Gastroparesis, delayed gastric emptying, NAFLD, decreased salivary secretions, increased ghrelin secretion by&#x000a0;the stomach, and gastric perforation or obstruction related to binge eating&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Musculoskeletal: Osteoporosis, fractures, scoliosis, kyphosis, and hip dysplasia&#x000a0;<xref ref-type="bibr" rid="article-27587.r24">[24]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Skin: Stasis ulcers and cellulitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Behavioral: Tantrums, outbursts, self-injury, food stealing and hoarding, delayed cognitive development, intellectual disabilities, and learning disabilities</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Neurologic: Hypotonia, temperature instability, and seizures&#x000a0;<xref ref-type="bibr" rid="article-27587.r2">[2]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Endocrine:&#x000a0;Short stature, GHD, central adrenal insufficiency, hypothyroidism, hypogonadism, and type 2 diabetes&#x000a0;<xref ref-type="bibr" rid="article-27587.r25">[25]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27587.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Clinicians caring for children should&#x000a0;maintain a high index of suspicion and&#x000a0;assess infants&#x000a0;displaying hypotonia, poor sucking, slow weight gain, or cryptorchidism for&#x000a0;Prader-Willi syndrome. Early diagnosis and&#x000a0;intervention can&#x000a0;effectively address&#x000a0;issues during infancy,&#x000a0;and family caregivers should receive education about&#x000a0;the developmental course of the condition. Children with&#x000a0;Prader-Willi syndrome require&#x000a0;meticulous dietary intervention to prevent severe obesity, along with comprehensive medical and educational services from a multidisciplinary approach.&#x000a0;</p>
      </sec>
      <sec id="article-27587.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about Prader-Willi syndrome include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Prader-Willi syndrome is a genetic disorder caused by the lack of expression of paternally inherited genes on chromosome 15q11-13, often due to a deletion in this region, maternal uniparental disomy (both copies from the mother), or imprinting defects.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Prader-Willi syndrome&#x000a0;is characterized by neonatal hypotonia, feeding difficulties, developmental delays, and later onset of hyperphagia leading to obesity. Distinct facial features may be present, such as almond-shaped eyes and a thin upper lip.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>DNA methylation analysis is a key diagnostic test, detecting abnormalities in over 99% of cases.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>There are 4 distinct phases, including hypotonia and poor feeding in infancy, followed by excessive eating and obesity starting around age 3. Behavioral issues, including food-seeking behaviors, are common.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Individuals with&#x000a0;Prader-Willi syndrome&#x000a0;are typically infertile. Both males and females may exhibit premature adrenarche, and advanced bone age is correlated with obesity.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Central obesity is a characteristic feature that leads to significant health complications and increased morbidity and mortality.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27587.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Prader-Willi syndrome is a complex genetic disorder&#x000a0;resulting from&#x000a0;a defect on chromosome 15.&#x000a0;Healthcare practitioners&#x000a0;should&#x000a0;suspect this diagnosis when&#x000a0;an infant demonstrates significant hypotonia, difficulty feeding, and slow weight gain, followed by hyperphagia that&#x000a0;results in&#x000a0;severe obesity.&#x000a0;Upon&#x000a0;diagnosis, it is crucial to incorporate an interprofessional team, including consultations with genetics, endocrinology, and developmental medicine, to monitor the progression of the&#x000a0;patient's symptoms&#x000a0;and prevent and treat complications. Parents should&#x000a0;undergo genetic counseling to estimate recurrence risk in future pregnancies.</p>
        <p>A nutritionist or registered dietitian can provide&#x000a0;essential dietary advice for infants to&#x000a0;facilitate appropriate weight gain and&#x000a0;mitigate the risk of severe obesity and its complications. Infants may require evaluation by a feeding team to enable appropriate weight gain&#x000a0;during the first year. Children under&#x000a0;3 should participate in Early Intervention to assess and treat global developmental delays. Older pediatric patients require an&#x000a0;IEP at school that may include speech, physical, and occupational therapy.</p>
        <p>A board-certified clinical pharmacist assists with&#x000a0;dosing hormonal replacement medication when indicated. Nursing staff monitor and&#x000a0;document the patient's response to treatment at each visit, charting growth and laboratory results to allow the clinical team&#x000a0;to modify the regimen as needed. Nurses support families and coordinate care for individuals with&#x000a0;Prader-Willi syndrome with specialized nutritional, behavioral, and educational needs. A mental health nurse&#x000a0;is a valuable interprofessional team member, assisting affected individuals and their caregivers. Psychiatrists and psychiatric nurse practitioners prescribe medication for mood disorders and psychoses. Visiting nurses&#x000a0;conduct home visits and&#x000a0;help families with practical techniques to manage food-seeking behaviors safely. Patients with orthopedic problems benefit from physical and occupational therapy, enabling them to perform activities of daily living. This interprofessional team approach is necessary to optimize clinical outcomes, reduce morbidity, and improve the quality of life and longevity of patients with&#x000a0;Prader-Willi syndrome.</p>
      </sec>
      <sec id="article-27587.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27587&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27587">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/prader-willi-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27587">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27587/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27587">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-27587.s16">
        <fig id="article-27587.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Prader-Willi Syndrome Phenotype. The child is 15 years of age with the Prader-Willi phenotype.&#x000a0;Note the absence of typical Prader-Willi syndrome&#x000a0;facial features. Mild truncal obesity can be noted. Contributed by Wikimedia Commons, Sch&#x000fc;le B et al (CC by 2.0) https://creativecommons.org/licenses/by/2.0/</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Pws" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-27587.s17">
        <title>References</title>
        <ref id="article-27587.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heksch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kamboj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anglin</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Obrynba</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Review of Prader-Willi syndrome: the endocrine approach.</article-title>
            <source>Transl Pediatr</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>274</fpage>
            <page-range>274-285</page-range>
            <pub-id pub-id-type="pmid">29184809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Manzardo</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Forster</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches.</article-title>
            <source>Curr Pediatr Rev</source>
            <year>2016</year>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>136</fpage>
            <page-range>136-66</page-range>
            <pub-id pub-id-type="pmid">26592417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pacoricona Alfaro</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Lemoine</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ehlinger</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Molinas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Diene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Valette</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coupaye</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poitou-Bernert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thuilleaux</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Arnaud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tauber</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2019</year>
            <month>Nov</month>
            <day>04</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>238</fpage>
            <pub-id pub-id-type="pmid">31684997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bohonowych</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McCandless</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>TV</given-names>
              </name>
            </person-group>
            <article-title>The Global Prader-Willi Syndrome Registry: Development, Launch, and Early Demographics.</article-title>
            <source>Genes (Basel)</source>
            <year>2019</year>
            <month>Sep</month>
            <day>14</day>
            <volume>10</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">31540108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cassidy</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Driscoll</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Prader-Willi syndrome.</article-title>
            <source>Genet Med</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-26</page-range>
            <pub-id pub-id-type="pmid">22237428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Prader-Willi syndrome: current understanding of cause and diagnosis.</article-title>
            <source>Am J Med Genet</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>319</fpage>
            <page-range>319-32</page-range>
            <pub-id pub-id-type="pmid">2309779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Passone</surname>
                <given-names>CBG</given-names>
              </name>
              <name>
                <surname>Pasqualucci</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Mattar</surname>
                <given-names>LBF</given-names>
              </name>
              <name>
                <surname>Koiffmann</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Soster</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Carneiro</surname>
                <given-names>JDA</given-names>
              </name>
              <name>
                <surname>Cabral Menezes-Filho</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Damiani</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>PRADER-WILLI SYNDROME: WHAT IS THE GENERAL PEDIATRICIAN SUPPOSED TO DO? - A REVIEW.</article-title>
            <source>Rev Paul Pediatr</source>
            <year>2018</year>
            <season>Jul-Sep</season>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>345</fpage>
            <page-range>345-352</page-range>
            <pub-id pub-id-type="pmid">30365815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angulo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Cataletto</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>38</volume>
            <issue>12</issue>
            <fpage>1249</fpage>
            <page-range>1249-63</page-range>
            <pub-id pub-id-type="pmid">26062517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lynn</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Driscoll</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Goldstone</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kimonis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Dykens</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Shuster</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Driscoll</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Nutritional phases in Prader-Willi syndrome.</article-title>
            <source>Am J Med Genet A</source>
            <year>2011</year>
            <month>May</month>
            <volume>155A</volume>
            <issue>5</issue>
            <fpage>1040</fpage>
            <page-range>1040-9</page-range>
            <pub-id pub-id-type="pmid">21465655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellis</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Kuhn</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mullarkey</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The consequences of hyperphagia in people with Prader-Willi Syndrome: A systematic review of studies of morbidity and mortality.</article-title>
            <source>Eur J Med Genet</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>104379</fpage>
            <pub-id pub-id-type="pmid">34748997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cummings</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Clement</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Vaisse</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Frayo</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Basdevant</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weigle</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Elevated plasma ghrelin levels in Prader Willi syndrome.</article-title>
            <source>Nat Med</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>7</issue>
            <fpage>643</fpage>
            <page-range>643-4</page-range>
            <pub-id pub-id-type="pmid">12091883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haqq</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Farooqi</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>O'Rahilly</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stadler</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Pratt</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>LaFranchi</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>JQ</given-names>
              </name>
            </person-group>
            <article-title>Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>88</volume>
            <issue>1</issue>
            <fpage>174</fpage>
            <page-range>174-8</page-range>
            <pub-id pub-id-type="pmid">12519848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crin&#x000f2;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schiaffini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ciampalini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Spera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beccaria</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Benzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bosio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Corrias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gargantini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salvatoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tonini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Trifir&#x000f2;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Livieri</surname>
                <given-names>C</given-names>
              </name>
              <collab>Genetic Obesity Study Group of Italian Society of Pediatric endocrinology and diabetology (SIEDP)</collab>
            </person-group>
            <article-title>Hypogonadism and pubertal development in Prader-Willi syndrome.</article-title>
            <source>Eur J Pediatr</source>
            <year>2003</year>
            <month>May</month>
            <volume>162</volume>
            <issue>5</issue>
            <fpage>327</fpage>
            <page-range>327-33</page-range>
            <pub-id pub-id-type="pmid">12692714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Hypopigmentation: a common feature of Prader-Labhart-Willi syndrome.</article-title>
            <source>Am J Hum Genet</source>
            <year>1989</year>
            <month>Jul</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>140</fpage>
            <page-range>140-6</page-range>
            <pub-id pub-id-type="pmid">2741944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r15">
          <label>15</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Driscoll</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cassidy</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <chapter-title>Prader-Willi Syndrome</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>1998</year>
            <month>10</month>
            <day>6</day>
            <pub-id pub-id-type="pmid">20301505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strom</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Hossain</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Grigorian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fierro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scaringe</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yen</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Teguh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>A Streamlined Approach to Prader-Willi and Angelman Syndrome Molecular Diagnostics.</article-title>
            <source>Front Genet</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>608889</fpage>
            <pub-id pub-id-type="pmid">34046054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Wattum</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Scheimann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salehi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brokamp</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fairbrother</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Childers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shelton</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bingham</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Shoemaker</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>A multidisciplinary approach to the clinical management of Prader-Willi syndrome.</article-title>
            <source>Mol Genet Genomic Med</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>e514</fpage>
            <pub-id pub-id-type="pmid">30697974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bennett</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Germani</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Haqq</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Zwaigenbaum</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Autism spectrum disorder in Prader-Willi syndrome: A systematic review.</article-title>
            <source>Am J Med Genet A</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>167A</volume>
            <issue>12</issue>
            <fpage>2936</fpage>
            <page-range>2936-44</page-range>
            <pub-id pub-id-type="pmid">26331980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wakimoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Filangieri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pinkhasov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Angulo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Guanfacine Extended Release for the Reduction of Aggression, Attention-Deficit/Hyperactivity Disorder Symptoms, and Self-Injurious Behavior in Prader-Willi Syndrome-A Retrospective Cohort Study.</article-title>
            <source>J Child Adolesc Psychopharmacol</source>
            <year>2019</year>
            <month>May</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>313</fpage>
            <page-range>313-317</page-range>
            <pub-id pub-id-type="pmid">30724590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alves</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Prader-Willi syndrome: endocrine manifestations and management.</article-title>
            <source>Arch Endocrinol Metab</source>
            <year>2020</year>
            <season>May-Jun</season>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>223</fpage>
            <page-range>223-234</page-range>
            <pub-id pub-id-type="pmid">32555988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheon</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome.</article-title>
            <source>Ann Pediatr Endocrinol Metab</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>126</fpage>
            <page-range>126-135</page-range>
            <pub-id pub-id-type="pmid">27777904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Manzardo</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Heinemann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Loker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Loker</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Causes of death in Prader-Willi syndrome: Prader-Willi Syndrome Association (USA) 40-year mortality survey.</article-title>
            <source>Genet Med</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>635</fpage>
            <page-range>635-642</page-range>
            <pub-id pub-id-type="pmid">27854358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pullen</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Picone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sannar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pfalzer</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Shelton</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zee</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Glaze</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Revana</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of sleep disorders in Prader-Willi syndrome.</article-title>
            <source>J Clin Sleep Med</source>
            <year>2022</year>
            <month>Jun</month>
            <day>01</day>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>1687</fpage>
            <page-range>1687-1696</page-range>
            <pub-id pub-id-type="pmid">35172921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greggi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Martikos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lolli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bakaloudis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Silvestre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Br&#x000f2;dano</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Giacomini</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment of scoliosis in patients affected with Prader-Willi syndrome using various techniques.</article-title>
            <source>Scoliosis</source>
            <year>2010</year>
            <month>Jun</month>
            <day>15</day>
            <volume>5</volume>
            <fpage>11</fpage>
            <pub-id pub-id-type="pmid">20550681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27587.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2017</year>
            <month>Aug</month>
            <day>30</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>146</fpage>
            <pub-id pub-id-type="pmid">28854950</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
